![Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics [electronic resource] /](/search/themes/bootstrap3/images/libros.png)
Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics [electronic resource] /
Some philosophical aspects of Alzheimer’s discovery: an American perspective -- The aging brain and its disorders -- Epidemiology of Alzheimer’s disease -- Descriptive and analytic epidemiology of Alzheimer’s disease -- A proposed classification of familial Alzheimer’s disease based on analysis of 32 multigeneration pedigrees -- Morphology of Alzheimer’s disease and related disorders -- Morphology of white matter, subcortical, dementia in Alzheimer’s disease -- Morphology of the cerebral cortex in relation to Alzheimer’s dementia -- Quantitative investigations of presenile and senile changes of the human entorhinal region -- Neuronal plasticity of the septo-hippocampal pathway in patients suffering from dementia of Alzheimer type -- Morphology of neurofibrillary tangles and senile plaques -- An in vitro model for the study of the neurofibrillary degeneration of the Alzheimer type -- Molecular and cellular changes associated with neurofibrillary tangles and senile plaques -- Brain abnormalities in aged monkeys: a model sharing features with Alzheimer’s disease -- Aged dogs: an animal model to study beta-protein amyloidogenesis -- Immunocytochemical and ultrastructural pathology of nerve cells in Alzheimer’s disease and related disorders -- Choline-acetyltransferase immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer’s disease -- Calbindin immunoreactive _eurons in Alzheimer-type dementia -- Lactate production and glycolytic enzymes in sporadic and familial Alzheimer’s disease -- Impairment of cerebral glucose metabolism parallels learning and memory dysfunctions after intracerebral streptozotocin -- Choline levels, the regulation of acetylcholine and phosphatidylcholine synthesis, and Alzheimer’s disease -- Acetylcholine synthesis and membrane phospholipids -- Hippocampal and cardiovascular effects of muscarinic agents -- Cholinergie and monoaminergic neuromediator systems in DAT. Neuropathological and neurochemical findings -- Alterations in catecholamine neurons in the locus coeruleus in dementias of Alzheimer’s and Parkinson’s disease -- Tyrosine hydroxylase, tryptophan hydroxylase, biopterin and neopterin in the brains and biopterin and neopterin in sera from patients with Alzheimer’s disease -- Postreceptorial enhancement of neurotransmission for the treatment of cognitive disorders -- Excitatory dicarboxylic amino acid and pyramidal neurone neurotransmission of the cerebral cortex in Alzheimer’s disease -- The sequence within the two polyadenylation sites of the A4 amyloid peptide precursor stimulates the translation -- Alzheimer-like changes of cortical amino acid transmitters in elderly Down’s syndrome -- Characteristics of learning deficit induced by ibotenic acid lesion of the frontal cortex in rats -- Memory loss by glutamate antagonists: an animal model of Alzheimer’s disease? -- Convulsant properties of methylxanthines, potential cognitive enhancers in dementia syndromes -- Neurodegenerative diseases: CSF amines, lactate and clinical findings -- Somatostatin-like immunoreactivity and neurotransmitter metabolites in the cerebrospinal fluid of patients with senile dementia of Alzheimer type and Parkinson’s disease -- Nerve growth factor in serum of patients with dementia (Alzheimer type) -- Neuroendocrine dysfunction in early-onset Alzheimer’s disease -- Urinary excretion of salsolinol enantiomers and 1,2-dehydrosalsolinol in patients with degenerative dementia -- Alzheimer’s disease — one, two or several? -- Diagnostic criteria of Alzheimer’s disease -- Clinical diagnosis of Alzheimer’s disease: DSM-III-R, ICD-10 — what else? -- Clinical aspects and terminology of dementing syndromes -- Symptoms of depression in the course of multi-infarct dementia and dementia of Alzheimer’s type -- Cognitive deterioration and dementia outcome in depression: the search for prognostic factors -- Diagnostic significance of language evaluation in early stages of Alzheimer’s disease -- The Alzheimer patient in the family context: how to help the family to cope -- Towards a clinically specific profile of severe senile primary degenerative dementia of the Alzheimer type (PDDAT) -- Sequential clinical approach to differential diagnosis of dementia -- Do old patients with Down’s syndrome develop premature brain atrophy? -- Results of EEG brain mapping and neuroimaging methods in Senile Dementia of Alzheimer’s Typ (SDAT) and Vascular Dementia (VD) -- Regulation of EEG delta activity by the cholinergic nucleus basalis -- EEG- and cognitive changes in Alzheimer’s disease — a correlative follow-up study -- Decreased hippocampal metabolic rate in patients with SDAT assessed by positron emission tomography during olfactory memory task -- PET criteria for diagnosis of Alzheimer’s disease and other dementias -- Oxygen metabolism in the degenerative dementias -- Positron emission tomography for differential diagnosis of dementia: a case of familial dementia -- Comparison between cerebral glucose metabolism and late evoked potentials in patients with Alzheimer’s disease -- High resolution regional cerebral blood flow measurements in Alzheimer’s disease and other dementia disorders -- Single photon emission computed tomography (SPECT) in Pick’s disease: two case reports -- In vivo studies of hippocampal atrophy in Alzheimer’s disease -- Outline for the evaluation of nootropic drugs -- Drug treatment of dementia -- Cognitive enhancing properties of antagonist ?-carbolines: new insights into clinical research on the treatment of dementias? -- Long term treatment of SDAT patients with pyritinol -- Listed in Current Contents.
| Main Authors: | , , , |
|---|---|
| Format: | Texto biblioteca |
| Language: | eng |
| Published: |
Vienna : Springer Vienna : Imprint: Springer,
1990
|
| Subjects: | Medicine., Neurosciences., Nuclear medicine., Endocrinology., Neurology., Pathology., Psychiatry., Medicine & Public Health., Nuclear Medicine., |
| Online Access: | http://dx.doi.org/10.1007/978-3-7091-3396-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Some philosophical aspects of Alzheimer’s discovery: an American perspective -- The aging brain and its disorders -- Epidemiology of Alzheimer’s disease -- Descriptive and analytic epidemiology of Alzheimer’s disease -- A proposed classification of familial Alzheimer’s disease based on analysis of 32 multigeneration pedigrees -- Morphology of Alzheimer’s disease and related disorders -- Morphology of white matter, subcortical, dementia in Alzheimer’s disease -- Morphology of the cerebral cortex in relation to Alzheimer’s dementia -- Quantitative investigations of presenile and senile changes of the human entorhinal region -- Neuronal plasticity of the septo-hippocampal pathway in patients suffering from dementia of Alzheimer type -- Morphology of neurofibrillary tangles and senile plaques -- An in vitro model for the study of the neurofibrillary degeneration of the Alzheimer type -- Molecular and cellular changes associated with neurofibrillary tangles and senile plaques -- Brain abnormalities in aged monkeys: a model sharing features with Alzheimer’s disease -- Aged dogs: an animal model to study beta-protein amyloidogenesis -- Immunocytochemical and ultrastructural pathology of nerve cells in Alzheimer’s disease and related disorders -- Choline-acetyltransferase immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer’s disease -- Calbindin immunoreactive _eurons in Alzheimer-type dementia -- Lactate production and glycolytic enzymes in sporadic and familial Alzheimer’s disease -- Impairment of cerebral glucose metabolism parallels learning and memory dysfunctions after intracerebral streptozotocin -- Choline levels, the regulation of acetylcholine and phosphatidylcholine synthesis, and Alzheimer’s disease -- Acetylcholine synthesis and membrane phospholipids -- Hippocampal and cardiovascular effects of muscarinic agents -- Cholinergie and monoaminergic neuromediator systems in DAT. Neuropathological and neurochemical findings -- Alterations in catecholamine neurons in the locus coeruleus in dementias of Alzheimer’s and Parkinson’s disease -- Tyrosine hydroxylase, tryptophan hydroxylase, biopterin and neopterin in the brains and biopterin and neopterin in sera from patients with Alzheimer’s disease -- Postreceptorial enhancement of neurotransmission for the treatment of cognitive disorders -- Excitatory dicarboxylic amino acid and pyramidal neurone neurotransmission of the cerebral cortex in Alzheimer’s disease -- The sequence within the two polyadenylation sites of the A4 amyloid peptide precursor stimulates the translation -- Alzheimer-like changes of cortical amino acid transmitters in elderly Down’s syndrome -- Characteristics of learning deficit induced by ibotenic acid lesion of the frontal cortex in rats -- Memory loss by glutamate antagonists: an animal model of Alzheimer’s disease? -- Convulsant properties of methylxanthines, potential cognitive enhancers in dementia syndromes -- Neurodegenerative diseases: CSF amines, lactate and clinical findings -- Somatostatin-like immunoreactivity and neurotransmitter metabolites in the cerebrospinal fluid of patients with senile dementia of Alzheimer type and Parkinson’s disease -- Nerve growth factor in serum of patients with dementia (Alzheimer type) -- Neuroendocrine dysfunction in early-onset Alzheimer’s disease -- Urinary excretion of salsolinol enantiomers and 1,2-dehydrosalsolinol in patients with degenerative dementia -- Alzheimer’s disease — one, two or several? -- Diagnostic criteria of Alzheimer’s disease -- Clinical diagnosis of Alzheimer’s disease: DSM-III-R, ICD-10 — what else? -- Clinical aspects and terminology of dementing syndromes -- Symptoms of depression in the course of multi-infarct dementia and dementia of Alzheimer’s type -- Cognitive deterioration and dementia outcome in depression: the search for prognostic factors -- Diagnostic significance of language evaluation in early stages of Alzheimer’s disease -- The Alzheimer patient in the family context: how to help the family to cope -- Towards a clinically specific profile of severe senile primary degenerative dementia of the Alzheimer type (PDDAT) -- Sequential clinical approach to differential diagnosis of dementia -- Do old patients with Down’s syndrome develop premature brain atrophy? -- Results of EEG brain mapping and neuroimaging methods in Senile Dementia of Alzheimer’s Typ (SDAT) and Vascular Dementia (VD) -- Regulation of EEG delta activity by the cholinergic nucleus basalis -- EEG- and cognitive changes in Alzheimer’s disease — a correlative follow-up study -- Decreased hippocampal metabolic rate in patients with SDAT assessed by positron emission tomography during olfactory memory task -- PET criteria for diagnosis of Alzheimer’s disease and other dementias -- Oxygen metabolism in the degenerative dementias -- Positron emission tomography for differential diagnosis of dementia: a case of familial dementia -- Comparison between cerebral glucose metabolism and late evoked potentials in patients with Alzheimer’s disease -- High resolution regional cerebral blood flow measurements in Alzheimer’s disease and other dementia disorders -- Single photon emission computed tomography (SPECT) in Pick’s disease: two case reports -- In vivo studies of hippocampal atrophy in Alzheimer’s disease -- Outline for the evaluation of nootropic drugs -- Drug treatment of dementia -- Cognitive enhancing properties of antagonist ?-carbolines: new insights into clinical research on the treatment of dementias? -- Long term treatment of SDAT patients with pyritinol -- Listed in Current Contents. |
|---|